KITAGAWA Kyoko

写真a

Affiliation

Faculty of Medicine School of Medicine Department of Anatomy, Ultrastructural Cell Biology

Title

Assistant Professor

Related SDGs


 

Papers 【 display / non-display

  • Subacute exposure to bisphenol F diglycidyl-ether induces chronic dermatitis characterized by psoriasis-like skin inflammation in mice Reviewed

    Kitagawa K., Shibata E., Yamamoto M., Harada H., Yoshino K., Iwashita T., Oshima M., Tsuji M.

    Genes to Cells   28 ( 1 )   42 - 52   2023.1

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Genes to Cells  

    Bisphenol F diglycidyl ether (BFDGE) is widely used in the synthesis process of plastic products. While exposure to bisphenol A diglycidyl ether (BADGE), which has a similar structure to BFDGE and which is used for the same purpose, has been reported to cause health risks, there is still little information on BFDGE. Because it is estimated that the industrial workers are exposed to large amounts of BFDGE, the health risks associated with BFDGE exposure need to be clarified. We investigated the toxicity of cutaneous exposure to BFDGE using an in vitro evaluation system and a mouse exposure model. The tumorigenic potential of BFDGE was confirmed by the Bhas 42 cell transformation assay, which showed that BFDGE has both promoter and initiator activity, in vitro. A single dermal application of BFDGE was associated with minor contact hypersensitivity symptoms. In contrast, repeated dermal exposure to BFDGE for 2 weeks induced persistent acute inflammation with features similar to inflammation in human psoriasis. This is the first report evaluating the toxicity of BFDGE in animals, and we showed that BFDGE carries a health risk of inducing skin dermatitis similar to that in human psoriasis in an exposure period-dependent manner.

    DOI: 10.1111/gtc.12995

    Scopus

    PubMed

  • Substitution of Thr572 to Ala in mouse c-Myb attenuates progression of early erythroid differentiation Reviewed

    Kitagawa K., Uchida C., Horiguchi R., Ohhata T., Sakai S., Niida H., Yasumoto S., Handa Y., Suzuki M., Hashimoto M., Tazawa T., Yokochi Y., Tsuji M., Kitagawa M.

    Scientific Reports   10 ( 1 )   14381   2020.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Scientific Reports  

    The expression level of transcription factor c-Myb oscillates during hematopoiesis. Fbw7 promotes ubiquitin-mediated degradation of c-Myb, which is dependent on phosphorylation of Thr572. To investigate the physiological relevance of Fbw7-mediated c-Myb degradation, we generated mutant mice carrying c-Myb-T572A (TA). Homozygous mutant (TA/TA) mice exhibited a reduction in the number of peripheral red blood cells and diminished erythroblasts in bone marrow, presumably as a result of failure during erythroblast differentiation. We found that c-Myb high-expressing cells converged in the Lin−CD71+ fraction, and the expression of c-Myb was higher in TA/TA mice than in wild-type mice. Moreover, TA/TA mice had an increased proportion of the CD71+ subset in Lin− cells. The c-Myb level in the Lin−CD71+ subset showed three peaks, and the individual c-Myb level was positively correlated with that of c-Kit, a marker of undifferentiated cells. Ultimately, the proportion of c-Mybhi subgroup was significantly increased in TA/TA mice compared with wild-type mice. These results indicate that a delay in reduction of c-Myb protein during an early stage of erythroid differentiation creates its obstacle in TA/TA mice. In this study, we showed the T572-dependent downregulation of c-Myb protein is required for proper differentiation in early-stage erythroblasts, suggesting the in vivo significance of Fbw7-mediated c-Myb degradation.

    DOI: 10.1038/s41598-020-71267-5

    Scopus

    PubMed

  • Largescale semithin sectioning method supported by a stainless steel ring enables multiscale analysis in transmission electron microscopy. Reviewed

    Takahashi N, Kitagawa K, Nagashima Y, Imazato H, Sawaguchi A

    Scientific reports   2026.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-026-61667-4

    PubMed

  • Caregiver-initiated food avoidance and risk of iron deficiency anemia in early childhood: Evidence from the Japan environment and children's study. Reviewed

    Tanaka R, Tsuji M, Ishitsuka K, Sakuragi T, Kitagawa K, Kuwamura M, Suga R, Araki S, Maruyama T, Eguchi H, Shibata E, Morokuma S, Shimono M, Yoshino K, Hamada N, Ochiai M, Ohga S, Kusuhara K, Japan Environment and Children's Study (JECS) Group

    Nutrition and health   2601060261461106   2026.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1177/02601060261461106

    PubMed

  • Measurement of Bisphenol A Diglycidyl Ether (BADGE), BADGE derivatives, and Bisphenol F Diglycidyl Ether (BFDGE) in Japanese infants with NICU hospitalization history Reviewed

    Kuwamura M., Tanaka K., Onoda A., Taki K., Koriyama C., Kitagawa K., Kawamoto T., Tsuji M.

    BMC Pediatrics   24 ( 1 )   26   2024.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMC Pediatrics  

    Background: Bisphenol A diglycidyl ether (BADGE) and Bisphenol F diglycidyl ether (BFDGE) are used in medical devices, such as intravenous sets, syringes, and catheters. Several studies have reported that these compounds are endocrine disruptors, cytotoxic, and genotoxic, raising concerns about their adverse effects on infants, in a stage of remarkable growth and development. The present study aimed to measure the serum concentrations of BADGE, derivatives of BADGE, and BFDGE in infants and examine the factors that influence them. Methods: Ten infants admitted to the neonatal intensive care unit (NICU) were enrolled in the present study. Blood samples from each infant and questionnaires from their mothers were collected twice, at 1–2 months and 7 months of age. BADGE, BADGE·H2O, BADGE·2H2O, and BFDGE were quantified using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Results: Serum BADGE·2H2O was identified in all infants, at both 1–2 months (2.30–157.58 ng/ml) and 7 months of age (0.86–122.85 ng/ml). One of the two infants who received invasive ventilation showed a substantially increased BADGE·2H2O concentration. There was no significant difference in BADGE·2H2O concentrations at 7 months of age between the group that ate commercial baby food at least ≥ 1 time per week and the group that did not. Conclusions: BADGE·2H2O was detected in the serum of all infants with a history of NICU hospitalization. Future studies are needed to determine the source of BADGE exposure and investigate its effects on infant development.

    DOI: 10.1186/s12887-023-04493-1

    Scopus

    PubMed

display all >>

Grant-in-Aid for Scientific Research 【 display / non-display

  • ゲノム編集オルガノイド由来プレクニカルモデルによるスキルス胃がん発生進展の解明

    Grant number:23K06662  2023.04 - 2026.03

    独立行政法人日本学術振興会  科学研究費基金  基盤研究(C)

      More details

    Authorship:Principal investigator